Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Array Biopharma
Array Biopharma
(ARRY)
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Braftovi
Encorafenib
2018-06-27
2029-2033
Colorectal neoplasms
,
Melanoma
Mektovi
Binimetinib
2018-06-27
2023-2033
Melanoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Binimetinib
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
gastrointestinal stromal tumors
,
disease progression
,
gene rearrangement
,
bcr-abl positive chronic myelogenous leukemia
,
lung neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
neoplasms
,
leukemia
,
myeloid leukemia
,
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
plexiform neurofibroma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
cutaneous malignant melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
myeloid leukemia acute
,
biliary tract neoplasms
,
lymphoma
Encorafenib
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
brain neoplasms
,
neoplasm metastasis
,
neoplasms
,
non-small-cell lung carcinoma
,
colonic neoplasms
,
lung neoplasms
,
adenocarcinoma
,
colorectal neoplasms
,
biliary tract neoplasms
,
melanoma
Sacituzumab
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
triple negative breast neoplasms
Ivuxolimab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
Utomilumab
follicular lymphoma
,
renal cell carcinoma
,
non-hodgkin lymphoma
,
squamous cell carcinoma of head and neck
,
melanoma
,
breast neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
oropharyngeal neoplasms
,
lip neoplasms
,
neoplasms
,
lymphoma
,
b-cell lymphoma
,
large b-cell lymphoma diffuse
,
non-small-cell lung carcinoma
,
ovarian neoplasms
Gilvetmab
castration-resistant prostatic neoplasms
,
virus diseases
,
herpesviridae infections
,
prostatic neoplasms
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
neoplasms
,
leukemia
,
hematologic diseases
,
b-cell chronic lymphocytic leukemia
,
bone marrow diseases
,
carcinoma
,
small cell carcinoma
,
small cell lung carcinoma
,
neuroendocrine carcinoma
,
colorectal neoplasms
,
colonic neoplasms
,
colonic diseases
,
multiple myeloma
,
plasma cell neoplasms
Varlitinib
pancreatic neoplasms
,
neoplasms
Buparlisib
melanoma
,
colorectal neoplasms
Edrecolomab
cystic fibrosis
,
fibrosis
Serine
non-small-cell lung carcinoma
Bevifimod
chronic hepatitis b
,
chronic hepatitis
,
hepatocellular carcinoma
,
liver neoplasms
Doxecitine
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma of lung
FILANESIB
multiple myeloma
,
paraproteinemias
,
plasmacytoma
,
plasma cell leukemia
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
Nadide
plasma cell neoplasms
,
hematologic neoplasms
,
hepatic insufficiency
,
neoplasms
,
recurrence
,
lung neoplasms
,
neoplasm metastasis
,
malignant pleural effusion
,
multiple myeloma
,
precursor cell lymphoblastic leukemia-lymphoma
,
leukemia
,
lymphoid leukemia
,
lymphoma
,
colorectal neoplasms
Nepidermin
chronic renal insufficiency
,
kidney diseases
,
dyslipidemias
,
type 2 diabetes mellitus
,
diabetes mellitus
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use